A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

Name: A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
Published: 2021
License: Public Domain

ModernaTX, Inc. · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

messenger-rna

cytomegalovirus infection, mrna-1647, moderna, cytomegalovirus, cmv, cytomegalovirus vaccine, cytomegalovirus infections, cytomegalovirus congenital, virus diseases, infection viral, dna virus infections, messenger rna

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 911744
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.